Additional information
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM | |
Date AMM | |
Range |
Essential treatment for hypertension when monotherapy with Valsartan at a dose of 160 mg / day or when the combination of Valsartan (80 mg) / Hydrochlorothiazide (12.5 mg) is insufficient.
Specialty | |
---|---|
Dosage | |
Form | |
Presentation | |
Primary packaging | |
Specification | |
DCI | |
Classement VEIC | |
Therapeutic class | |
Laboratory | |
CHART | |
The duration of the conversation | |
Generic / Princeps | |
AMM | |
Date AMM | |
Range |